Theme: Solution To Eradicate Hematologic Oncology

Hematologic Oncology 2016

Hematologic Oncology 2016

 

Conferenceseries LLC invites all the participants from all over the world to attend ‘International Conference on Leukemia and Hematologic Oncology’ during October 17-18, 2016 in Rome, Italy. The conference will be organized around the theme “Solution to Eradicate Oncology”.

Hematologic Oncology 2016 welcomes haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Track 1. Leukemia

       Leukaemia is a malignancy (cancer) of blood cells. In leukemia, abnormal blood cells are produced in the bone marrow. Leukemia involves the production of abnormal white blood cells the cells responsible for struggling infection. The abnormal cells in leukemia not function in the same way as normal white blood cells. The leukemia cells continue to develop and divide, finally crowding out the normal blood cells. The end result is that it becomes tough for the body to fight infections, control haemorrhage, and carriage oxygen.

Related Conferences

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; International Conference on Oral, Mouth and Throat Cancer August 18-20, 2016 Portland, USA; Training course on  diagnosis and management of very rare Red cell and iron disorders January 29-30,2016           Libson,Portugal; International conference on aging and hematological malignancies: Biology and therapy March 11-13, 2016  Athens, Greece; 5th international conference on Myelodysplastic syndromes April 14-16, 2016  Estroil, Portugal; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary.

Breast Cancer Conferences  October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK, 12th Cancer Conferences Europe September 26-28, 2016 London, UK, 12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE,  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE

Track 2Hematology

Erythrocytes are also known as red blood cells which carry oxygen to the body and collect carbon dioxide from the body by the use of haemoglobin and its life span of 120 days. along the side the leucocytes helps in protecting the healthy cells because the W.B.C (leucocytes) act as the defending cells in protecting the immune system from the foreign cells. Formation of blood cellular components are called as Hematopoiesis and all the cellular blood components are derived from hematopoiesis stem cells in a healthy individual nearly 1011–1012  new blood cells are produced these help in steady peripheral circulation. If there is a increases of R.B.C in the body these causes polycythemia these can be measured through haematocrit level.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; Blood Cancer & Treatment Conferences  May 25-27, 2017 London, UK Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; Exhibition on Surgical Oncology  Conferences September 01-03,2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17,2016 Berlin,Germany;2nd International Conference on new concepts in B-cell malignancies September 9-11, 2016 Estroil, Portugal; 18th Annual john Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy September 15-18, 2016 Houston ,USA; 3rd International Conference on Multiple Myelomas October 7-9, 2016 Milan,  Italy; 7th International Conference on  Myeloproliferative neoplasms  October27-29, 2016 Estroil, Portugal;  9th World Congress on Regenerative medicine and Stem Cell South Korea 2016 March 16-18, 2016 Seoul, South Africa.

Track 3.Hematologic-oncology

Hematologic Oncology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. Haematology includes the study of etiologist involves treating diseases that affect the production of blood and its components, such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist. Haematologists also conduct studies in oncology and work with oncologists, people who may specialize only in that field instead of both-the medical treatment of cancer. There are various disorders that people are affected by haematology. A few of these different types of blood conditions that are looked at include anemia, haemophilia, general blood clots, bleeding disorders, etc. As for related blood cancers such as leukemia, myeloma, and lymphoma, these are more serious cases that need to be diagnosed

Related Conferences:

Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary.

Track 4 Oncology

The term oncology literally means a branch of science that deals with tumours and cancers. The word “onco” means bulk, mass, or tumor while “-logy” means study. Oncologic emergencies, as the term implies, are complications resulting from a cancer itself, a paraneoplastic syndrome, or from treatment of the cancer, that require immediate attention and reversal, Cancers are best managed by discussing in multi-disciplinary tumour boards where medical oncologist, surgical oncology, radiation oncology, pathologist, radiologist and organ specific oncologists meet to find the best possible management for an individual patient considering the physical, social, psychological, emotional and financial status of the patients. It is very important for oncologists to keep updated of the latest advancements in oncology as changes in management of cancer are quite common. All fit patients whose cancer progresses and no standard of care treatment options are available should be enrolled in a clinical trial. Oncologic emergencies, as the term implies, are complications resulting from a cancer itself, a paraneoplastic syndrome, or from treatment of the cancer, that require immediate attention and reversal, if possible. Inpatient treatment is a must, and often these conditions require intervention in an intensive care setting.

Related Conferences:

Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; Blood Cancer & Treatment Conferences  May 25-27, 2017 London, UK Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; Exhibition on Surgical Oncology  Conferences September 01-03,2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17,2016 Berlin,Germany;2nd International Conference on new concepts in B-cell malignancies September 9-11, 2016 Estroil, Portugal; 18th Annual john Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy September 15-18, 2016 Houston ,USA; 3rd International Conference on Multiple Myelomas October 7-9, 2016 Milan,  Italy; 7th International Conference on  Myeloproliferative neoplasms  October27-29, 2016 Estroil, Portugal;  9th World Congress on Regenerative medicine and Stem Cell South Korea 2016 March 16-18, 2016 Seoul, South Africa.

Track 5. Paediatric Oncology

The term 'pediatric oncologist' usually refers to physicians who have specialized in pediatrics and then received further training in medical oncology and hematology. The Paediatric Oncology Shared Care Unit (POSCU) is a multidisciplinary team of doctors, Macmillan paediatric oncology clinical nurse specialists, paediatric pharmacists and therapists providing chemotherapy and supportive care for children in Lambeth, Southwark and Lewisham who are being treated for cancer or leukaemia (blood cancer). Acute lymphoblastic leukemia, also known as acute lymphocytic leukemia or acute lymphoid leukemia (ALL), is an acute form of leukemia, or cancer of the white blood cells, characterized by the overproduction and accumulation of cancerous, immature white blood cells, known as lymphoblasts A brain tumor or intracranial neoplasm occurs when abnormal cells form within the brain. There are two main types of tumors: malignant or cancerous tumors and benign tumors.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary.

Track 6 Clinical Oncology

Clinical oncology is a very research-focussed specialty.  For systemic treatment, research starts with work in the laboratory to identify and characterise new drugs. ‘Translational’ research identifies compounds which show potential in the laboratory and facilitates their progression to clinical studies.  Finally, new treatments are tested in large-scale clinical trials to assess their impact in day-to-day practice.  For radiotherapy, modern technology is enabling research into new delivery techniques that make treatments more accurate than ever before.  Clinical oncologists have the opportunity to become involved at all stages in these exciting developments. With more patients surviving cancer than ever before, there is increasing emphasis on cancer survivorship.  There is renewed interest in minimising long term effects of cancer treatment and optimising quality of life.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; Blood Cancer & Treatment Conferences  May 25-27, 2017 London, UK Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; Exhibition on Surgical Oncology  Conferences September 01-03,2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17,2016 Berlin,Germany;2nd International Conference on new concepts in B-cell malignancies September 9-11, 2016 Estroil, Portugal; 18th Annual john Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy September 15-18, 2016 Houston ,USA; 3rd International Conference on Multiple Myelomas October 7-9, 2016 Milan,  Italy; 7th International Conference on  Myeloproliferative neoplasms  October27-29, 2016 Estroil, Portugal;  9th World Congress on Regenerative medicine and Stem Cell South Korea 2016 March 16-18, 2016 Seoul, South Africa.

Track 7. Oncologists

Medical professionals who practice oncology are called Cancer specialists or oncologists. These oncologists have several specific roles. They help in diagnosis of the cancer, help in staging the cancer and grading the aggressive nature of the cancer.A medical oncologist specializes in treating cancer with chemotherapy such as targeted therapy and oral (in pill form) chemotherapy. A surgical oncologist specializes in the removal of the tumor and surrounding tissue during an operation. And a radiation oncologist specializes in treating cancer with radiation therapy (the use of high-energy x-rays or other particles to kill cancer cells). Oncology Trials Insights (OTI) is a clinical trials strategy company; and is focused specifically in the oncology space. Gynaecologic Oncology is a field of study in which a doctor trains to become specialist in cancers of the female reproductive organs such as the ovaries, uterus, cervix, vagina, etc.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary..

Track 8. Blood Disorders and Blood oncology

Anemia is the most common type of blood disorder we treat. Patients with anemia have a deficiency of oxygen-rich red blood cells or their red blood cells do not function properly. A low level of hemoglobin, the iron-rich protein that carries the oxygen in red blood cells, signals the condition. Anemia can be chronic, or a temporary condition caused by other health issues, including cancer treatment, hepatitis C, and HIV/AIDS. Anemia frequently remains undiagnosed because it is an underlying condition of other health issues, including cancer, cardiovascular disease, diabetes, HIV/AIDS, inflammatory bowel disease, chronic kidney disease, and rheumatoid arthritis. Hemophilia is a rare, typically inherited blood disorder in which the blood does not properly clot and causes excessive bleeding, which can cause damage to organs, joints, and tissues. Patient may suffer excessive bleeding from the site of an injury or from internal bleeding. Clotting Disorders Hematologists also treat conditions related to the proteins that trigger bleeding and clotting, including thrombosis (clotting) and hemostasis (bleeding). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; Blood Cancer & Treatment Conferences  May 25-27, 2017 London, UK Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; Exhibition on Surgical Oncology  Conferences September 01-03,2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17,2016 Berlin,Germany;2nd International Conference on new concepts in B-cell malignancies September 9-11, 2016 Estroil, Portugal; 18th Annual john Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy September 15-18, 2016 Houston ,USA; 3rd International Conference on Multiple Myelomas October 7-9, 2016 Milan,  Italy; 7th International Conference on  Myeloproliferative neoplasms  October27-29, 2016 Estroil, Portugal;  9th World Congress on Regenerative medicine and Stem Cell South Korea 2016 March 16-18, 2016 Seoul, South Africa.

Track 9. Leukemia Causes and symptoms

The cause is generally different from other categories of cancer. Experts say that Blood Malignancies arise due to different reasons, some of them are assumed and some are yet to be. It is nearly impossible to prove what caused a blood cancer in any individual, because most blood cancers have multiple possible causes. Discussions will be carried out on the suspecting and suspected causes of blood cancer.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary.

Track 10.Leukemia Pathophysiology

Leukemias are a group of heterogeneous neoplastic disorders of white blood cells. Based on their origin, myeloid or lymphoid, they can be divided into two types. Leukaemia’s traditionally have been designated as acute or chronic, based on their untreated course. Acute leukaemia’s usually present as haemorrhage, anaemia, infection, or infiltration of organs. Many patients with chronic leukaemia are asymptomatic. Bleeding, thrombosis, or lymphadenopathy.

Related Conferences: 

Leukemia Conferences | Hematology Conferences |Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th Training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal.

Track 11. Leukemia risk factors

       Exposure to radiation is known to increase the risk of developing AML, CML, or ALL. Increases in leukemia were observed in people surviving atomic bombs. Radiation therapy for cancer can also increase the risk of leukemia. Exposure to benzene, used commonly in the chemical industry, increases the risk of leukemia. Cigarette smoking is known to increase the risk of developing AML.

Having risk factors does not mean that a person will definitely get leukemia, and most people with risk factors will not develop the disease. Likewise, not everyone who develops leukemia has an identifiable risk factor.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary.

Track 12. Leukemia:Staging

Leukemia stages vary based on disease type. And, some of the leukemias may be broken out into subtypes during the staging process.

The acute types of leukemia (AML and ALL), are sometimes staged based on the type of cell involved and how the cells look under a microscope.

Related Conferences: 

Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal.

Track 13. Leukemia: Diagnosis

To confirm the presence of cancer and the severity or the stages of the cancer various cancer detection tests are carried out; certain cancer blood tests or other laboratory tests, such as an analysis of your urine or a biopsy of a suspicious area, to help guide the diagnosis. With the exception of blood cancers, blood tests generally can't absolutely tell cancer or some other noncancerous condition, but they can give your doctor the clues about what's going on inside the body. 

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.

Track 14. Leukemia immunology

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumor marker-based diagnostic tests. 

Related Conferences:

 Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary.

Track 15.Oncology Case Report

CCR is currently recruiting Associate Editors to join our team specialising in Haematology and Oncology. Globally it is expected that there are 7.6 million new cancer cases per annum, out of which 52% happen in developing countries. Case reports should include relevant positive and negative findings from history, examination and investigation, and can include clinical photographs, provided these are accompanied by written consent to publish from the patient(s). Case reports should include an up-to-date review of all previous cases in the field.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal.

Track 16. Hemato Immunology &Stem Cell Research

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined  antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to. The disorder of immune system leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary.

Track 17.Cancer and pharmacology

Treatment often fails when cancer becomes resistant to anti-cancer drugs. Thus, drug resistance is a big challenge facing the survival of cancer patients. Research in discovering and designing drugs with new chemistry structure or mechanism of action is critical to overcome the drug resistance problem and give patient better chance to survive longer. Monoclonal antibody therapy is a form of immunotherapy that uses monoclonal antibodies (mAb) to specifically bind to specific cells or proteins. Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future.The clinical toxicology importance of any drug interaction depends on factors that are drug-patient and administration related. Generally, a doubling or more in plasma drug concentration has the potential for enhanced adverse or beneficial drug response Drug interactions in oncology are of particular importance owing to the narrow therapeutic index and the inherent toxicity of anticancer agents. Interactions with other medications can cause small changes in the pharmacokinetics or pharmacodynamics of a chemotherapy agent that could significantly alter its efficacy or toxicity.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal.

Track 18. Cancer: Treatment and Therapy

The branch of medicine that deals with the diagnosis and treatment of injury, deformity, and disease by the use of instruments. Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Refractive surgery is the term used to describe surgical procedures that correct common vision problems (nearsightedness, farsightedness, astigmatism and presbyopia) to reduce your dependence on prescription eyeglasses and/or contact lenses. Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. Hyperthermia is elevated body temperature due to failed thermoregulation that occurs when a body produces or absorbs more heat than it dissipates.

Related Conferences:

Leukemia Conferences | Hematology Conferences |Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal.

Track 19. Cancer :Diagnostics and Staging

X-radiation (composed of X-rays) is a form of electromagnetic radiation Magnetic resonance imaging (MRI) is a type of scan that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. An ultrasound scan, sometimes called a sonogram, is a procedure that uses high-frequency sound waves to create an image of part of the inside of the body. A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist involving sampling of cells or tissues for examination. A complete blood count (CBC) gives important information about the kinds and numbers of cells in the blood, especially red blood cells camera.gif, white blood cells camera.gif, and platelets. Cancer staging is the process of determining the extent to which a cancer has developed by spreading. The TNM Classification of Malignant Tumours (TNM) is a cancer staging notation system that gives codes to describe the stage of a person's cancer, when this originates with a solid tumor. Pathologic staging, where a pathologist examines sections of tissue, can be particularly problematic for two specific reasons: visual discretion and random sampling of tissue.

Related Conferences:

Leukemia Conferences | Hematology Conferences |Hematologic Oncology Conferences

4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 5th international conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training Course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; International Conference on aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary..

Track 20.Cancer and Alternative Medicine

Ayurvedic medicine is an ancient Indian system of medicine which began about 5,000 years ago. It is not just one treatment. It is a way of diagnosing illness and using a wide range of treatments and techniques. Herbal medicine uses plants, or mixtures of plant extracts, to treat illness and promote health. It aims to restore your body's ability to protect, regulate and heal itself. It is a whole body approach, so looks at your physical, mental and emotional well-being. It is sometimes called phytomedicine, phytotherapy or botanical medicine. Naturopathic doctors (NDs) believe that cancer arises from an imbalance that causes a systemic breakdown within the body. Homeopathy is based on the theory of treating like with like. So to treat an illness a homeopathic therapist (homeopath) uses tiny doses of a substance that in large doses would actually cause the symptoms of the illness.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal.

Track 21. Haematological malignancies

Hematologic malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes.Included in the MPN disease spectrum are essential thrombocythemia, polycythemia Vera  and myelofibrosis . This scientific session will focus on all types of common or rare blood cancers such as acute promyelocytic leukemia (APL) and chronic myelomonocytic leukemia hairy cell leukemia (HCL), large granular lymphocytic leukemia (LGL), t-cell acute lymphoblastic leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia and Myelodysplastic–Myeloproliferative diseases.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.Breast Cancer Conferences October 03-05, 2016 London, UK, Women’s Health Conferences October 03-05, 2016 London, UK, Oncology Conferences November 21-23, 2016 Dubai, UAE,  Worldwide Cancer Events November 21-23, 2016 Dubai, UAE

Track 22.Haematological malignancies: Prognosis

The estimate of how the disease will go for a patient is called prognosis. There are many factors affect prognosis that include: the type of cancer and where it is in the body, the stage of the cancer, the cancer’s grade. Grade provides clues about how quickly the cancer is likely to grow and spread certain traits of the cancer cells, the age and how healthy body was before cancer & how successful is the treatment.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.

Track 23. Myelodysplastic–Syndrome

The myelodysplastic syndromes (also known as MDS or myelodysplasia) are haematological medical conditions with ineffective production of all blood cells. In some cases, the disease worsens and the patient develops low blood counts caused by progressive bone marrow failure. The myelodysplastic syndromes are all disorders of the hematopoietic stem cells in the bone marrow. In MDS, blood production is disorderly and ineffective. The number and quality of blood-forming cells decline irreversibly, further impairing blood production. In this section detailed information about myelodysplastic syndromes will be discussed.

Related Conferences: 

Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.Breast Cancer Conferences  October 03-05, 2016 London, UK,12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE,  

Track 24. Childhood Hematological Cancers

Childhood blood cancers are rare. The major subtypes of childhood blood cancers are lymphoblastic, Burkitt, large B cell & anaplastic large cell. Treatment at special centres for children and teens provides the advantages of specialized care. In addition, childhood cancers tend to respond to treatment better than adult cancers do, and children's bodies often tolerate treatment better. Treatment may involve antibiotics, blood transfusions, or other measures to fight infection. In this section, we will be discussing about the various types of childhood blood cancers, symptoms included, their diagnosis & treatment options available.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies  and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.

Track 25. Biomarkers

Protein Biomarkers can be used as biomarkers for early detection of cancers especially used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a biopsy will be undertaken to confirm pancreatic cancer by H&E pathological analysis.  The presence of cancerous cells via pathology is very challenging due to high numbers of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will only commence on definitive diagnosis of pancreatic cancer. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been identified as a highly sensitive (98%) and specific (95%) IHC marker for pancreatic cancer and CRT is seeking a partner to develop an IHC based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies  and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.12th Oncology Conferences Europe September 26-28, 2016 London, UK, 12th Cancer Science Events Europe September 26-28, 2016 London, UK, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE, Oncology Conferences November 21-23, 2016 Dubai, UAE.

Track 26.Leukemia :Treatments and care

Treatment for your leukemia depends on many factors.

Chemotherapy is the major form of treatment for leukaemia. Biological therapy works by using treatments that help your immune system recognize and attack leukaemia cells. Targeted therapy uses drugs that attack specific vulnerabilities within your cancer cells.

Common treatments used to fight leukemia.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies  and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.

Track 27.Bone Marrow Transplantation and surgery

Bone Marrow Transplantation: A bone marrow transplant, also known as a haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow stem cells. Bone marrow is a spongy tissue found in the hollow centres of some bones. It contains specialist stem cells, which produce the body's blood cells.

A biopsy is a sample of tissue taken from the body in order to examine it more closely. A doctor should recommend a biopsy when an initial test suggests that an area of tissue in the body isn't normal. Doctors may call that area of abnormal tissue a lesion, a tumour, or a mass.Topics of discussion in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies  and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.

 Track 28.Advance in Bone Marrow Transplantation

An increasing number of diseases may be treated successfully by allogeneic bone marrow transplantation (BMT). Initially used for the treatment of immunodeficiency where a cell series or product is replaced, it has now become routine treatment for many forms of leukemia where the transplant provides the rescue after lethal marrow ablation. Recently, diseases such as thalassemia and other inherited metabolic diseases have also been treated by BMT. Formerly the problems of BMT were mainly concerned with graft versus host disease (GVHD) in HLA-matched transplants with HLA-mismatched ones not being possible as GVHD was usually fatal. Since the development of techniques for T cell removal the incidence of GVHD has greatly diminished. T cell removal has also allowed HLA haploidentical mismatched grafts to be performed successfully for immunodeficiency, but there is still a high graft rejection rate in leukemia. 

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Cancer Diagnostics Conference & Expo  June 13-15, 2016 Rome, Italy;  7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Mesothelioma November 03-04, 2016 Valencia, Spain; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th International Conference on Blood Malignancies  and Treatment April 18-20, 2016 Dubai, UAE; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14, 2016  Budapest, Hungary; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal.

Track 29.Cancer Clinical Trials

Clinical trials are studies in which people volunteer to take part in tests of new drugs or procedures. Doctors use clinical trials to develop new treatments for serious diseases such as cancer. In this section you can learn about clinical trials in general, find tools to help you decide if a clinical trial may be right for you, and search for specific studies you may be eligible to take part in. Clinical trials can vary in size and cost, and they can involve a single research centre or multiple centers, in one country or in multiple countries. Clinical study design aims to ensure the scientific validity and reproducibility of the results.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

International Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; Global Summit on Melanoma and Carcinoma July 14-15, 2016 Brisbane, Australia; International Conference and Exhibition on Surgical Oncology September 01-03, 2016 Sao Paulo, Brazil; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; International Conference on Aging and Hematological malignancies: Biology and Therapy March 11-13, 2016  Athens, Greece; 20th training course on Hematopoietic stem cell transplantation May 11-14,  2016  Budapest, Hungary; Training course on  Diagnosis and Management of very rare Red cell and Iron disorders January 29-30, 2016 Libson, Portugal; 5th International Conference on Myelodysplastic Syndromes April 14-16, 2016  Estroil, Portugal.

 

OMICS international invites all the participants across the globe to attend the "International Conference on Leukemia and Bonemarrow Transplantation (Leukemia 2016) slated on October17-18, 2016, Rome, Italy.

Leukemia 2016 will focus the latest and exciting innovations in allied areas of Leukemia and it will offer a unique opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions. Leukemia is cancer of the blood cells. It starts in the bone marrow, the soft tissue inside most bones. Bone marrow is where blood cells are made. When you have leukemia, the bone marrow starts to make a lot of abnormal white blood cells, called leukemia cells. An estimated combined total of 156,420 people are expected to be diagnosed with leukemia in 2014. New cases of leukemia are expected to account for 9.4 percent of the estimated 1,665,540 new cancer cases diagnosed in 2014. 

OMICS internationall is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80,000 editorial board members, and 7.5 million followers to its credit.

Why to attend?

With members from around the world focused on learning about Leukemia and Bone Marrow Transplantation; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Leukemia diagnosis, treatment and surgery involved are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event

Target Audience:

Hematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from Academia and Research along with the industrial professionals from biomedical companies and healthcare sectors.

Leukemia is the cancer of the white blood cells or the bone marrow, which occurs due to an abnormal increase in the count of white blood cells. It is identified by the spread of the diseases (either acute or chronic), and by the type of the blood cell that is affected (lymphocytic or myelocytic). This type of cancer can again be categorized into acute lymphoblastic leukemia (ALL), which accounts for about 12%, chronic lymphocytic leukemia (CLL) which accounts for 35%, acute myelogenous leukemia (AML) which accounts for 29%, and chronic myelogenous leukemia (CML) which accounts for 11% of the total leukemia.

                       Stastistical Analysis of Leukemia associations

The leukemia therapeutics market was valued at $6.3 billion in 2010 and is expected to reach $11.3 billion by 2020 at a CAGR of 3.84% between 2015 and 2020. The market was dominated by chronic myeloid leukemia in 2010. However, in 2020, the market is expected to be equally dominated by acute lymphocytic leukemia and chronic myeloid leukemia, with sales amounting to $3.91 billion and $3.58 billion respectively. 

 

According to WHO, leukemia is expected to be more prominent in the developed world such as North America and European countries due to genetic factor. The other causes such as environmental factor and radiation exposure are also the causative factors of all the types of leukemia.

                  Hospitals associated with Leukemia

The U.S. dominates the leukemia drug market in North America with 62% share; whereas Germany dominates the market of Europe with 31.05% share.

The major players in the market include F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (U.K.), Novartis International AG (Switzerland), Bristol-Myers Squibb (U.S.), Eisai Co. Ltd (Japan), Biogen Idec (U.S.), ERYtech Pharma (France) Celgene Corporation (U.S.), Genmab A/S (Denmark), Cephalon Inc. (U.S.), Clavis Pharma (Norway), and Pfizer Inc. (U.S.).

              Members Associated in Leukemia Research

 

Hematology 2015

Past Reports  Proceedings  Gallery  

Hematology-2014

"2nd International Conference on Hematology & Blood Disorders" organized by OMICS Group International was successfully held at Double Tree by Hilton Hotel BWI Airport at Baltimore, USA during September 29- October 01, 2014. The conference was organized around the theme “On the Path of Identifying Novel Therapeutics for Blood Disorders."

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 25 different countries ultimately driving the event into the path of success.

OMICS Group International would like to convey a warm gratitude to all the honorable guests of Hematology-2014, Mark Roschewski, National Institutes of Health, USA; E. Brad Thompson, University of Houston, USA; Britt Gustafsson, Center for Allogeneic Stem Cell Transplantation, Sweden; Effie Liakopoulou, Genimbi Inc, USA and Ping Xie, Rutgers University, USA

The highlights of the conference were its educative and effectual keynote lectures by:

  • E. Brad Thompson, University of Houston, USA
  • Mark Roschewski, National Institutes of Health, USA
  • Britt Gustafsson, Center for Allogeneic Stem Cell Transplantation, Sweden
  • Knox Van Dyke, West Virginia University, USA
  • Effie Liakopoulou, Genimbi Inc, USA
  • Keith Van Meter, Louisiana State University Health Sciences Center, USA
  • Shimon Slavin, The International Center for Cell Therapy & Cancer Immunotherapy, Israel

The conference proceedings were carried out with fabulous plenary lectures from the speakers of various universities and organizations like

  • Johns Hopkins Bloomberg School of Public Health, USA
  • National Institutes of Health, USA
  • Medical University of South Carolina, USA
  • Children's Hospital of Wisconsin, USA
  • Indiana University Simon Cancer Center, USA
  • University of California‐Irvine, USA
  • Children's National Medical Center, USA
  • Johns Hopkins University, USA
  • West Virginia Medical School, USA
  • University of Colorado, USA
  • Rutgers University, USA
  • Stony Brook University Medical Center, USA
  • The Icahn School of Medicine, USA
  • The Wright Center for Graduate Medical Education, USA

OMICS Group also took the privilege of felicitating Hematology-2014 Organizing Committee, Editorial Board Members and Keynote Speakers whose support led the conference into the path of excellence. Our special gratitude to our exhibitor One Lambda, USA and media partners All Congress, Business Vibes, Clocate, Medical News Today, Oncology Education and ORIC Publications


Past Reports  Proceedings  Gallery  

Hematology-2013

The International Conference on Hematology & Blood Disorders, organized by OMICS Group International was successfully held at Double Tree by Hilton Hotel Raleigh-Durham Airport at RTP, NC, USA during September 23-25, 2013. The conference was organized around the theme “Exploring Novel Trends in Treating Hematological Disorders."

The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates representing more than 25 different countries ultimately driving the event into the path of success.

OMICS Group International would like to convey a warm gratitude to all the honorable guests of Hematology-2013, Owen A. O’ Connor, Columbia University, USA; Mark Guthridge, Monash University, Australia; Raul H. Morales-Borges, American Red Cross, USA, Gabriela Gheorghe, Medical College of Wisconsin, USA and Dale Christensen, Oncotide pharmaceuticals, USA.

The highlights of the conference were its educative and effectual keynote lectures by:

Owen A. O’ Connor, Columbia University, USA
Joseph A. Trapani, Peter MacCallum Cancer Centre, Australia
Prithviraj Bose, Virginia Commonwealth University, USA
Joy G. Mohanty, National Institute of Aging, NIH, USA
Dale Christensen, Oncotide pharmaceuticals, USA.

The conference proceedings were carried out with fabulous plenary lectures from the speakers of various universities and organizations like

Medical University of South Carolina, USA

Mayo Clinic, USA

West Virginia Medical School, USA

University of Colorado Denver, USA

University of North Carolina at Chapel Hill, USA

University of Southern California, USA

National Institute of Allergy and Infectious Diseases, NIH, USA

University of California Los Angeles, USA

National Institute of Dental and Craniofacial Research, NIH, USA

The Scripps Research Institute, USA

OMICS Group also took the privilege of felicitating Hematology-2013 Organizing Committee, Editorial Board Members and Keynote Speakers whose support led the conference into the path of excellence. Our special gratitude to our sponsor Thalessemia International Federation, exhibitor Lippincott Williams and Wilikins and media partners Bristish Society of Haematology, Liverpool; Thalessemia International Federation; MD Conference finder; Science and Education Publishing.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 17-18,2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations